Projects per year
Personal profile
Education
- 2010-2013 Ph.D., Biomedical Electronics and Bioinformatics, National Taiwan University Hospital
- 1981-1997 M.D., Department of Medicine, Chang-Gung University
Experience
- 2021.08- Director, Division of Thoracic Medicine, Department of Internal Medicine, Taipei Municipal Wanfang Hospital
- 2020.02- Associate Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2019.08- Assistant Professor, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2019.05-2019.07 Assistant Professor, Preparatory Office, Professional Master Program in Artificial Intelligence in Medicine, College of Medicine, Taipei Medical University
- 2014- Chief, Tuberculosis Center, Taipei Municipal Wanfang Hospital
- 2014.11 Attending Physician, Division of Pulmonary Medicine, Wanfang Hospital
- 2014.11-2020.01 Assistant Professor, Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University
- 2004-2013 Attending Physician, Taipei Tzu Chi Hospital
- 2003.07-2004.10 Attending Physician, Far Eastern Memorial Hospital
Awards
- 2019 Affiliated Hospital Research Project Award, Taipei Medical University
- 2014 Best reviewer of Pharmacoepidemiology and Drug Safety.
Research Interests
- Tuberculosis
- Chronic obstructive pulmonary disease
- Health Information Database
- Critical Care Medicine
Fingerprint
Dive into the research topics where Chih-hsin Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Elucidating the Association of Toll-Like Receptor II Mediated Immune Cell Response and Susceptibility to Tuberculosises in Patients with Diabetes Mellitus
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性-III
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
穿戴式裝置於老人及高風險結核病病人偵測因藥物導致的QT間距延長之能力探討
1/1/19 → 12/31/19
Project: C - Project of Alliance › j - National Taipei University of Technology
-
分析結核病接觸者周邊血調節型T淋巴球與潛伏結核感染的關聯性
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestation
Putri, D. U., Huang, C-K., Ou, T-Y., Lin, C-F., Lee, M-C., Hung, C-S. & Lee, C-H., 2023, In: Journal of Infection.Research output: Contribution to journal › Article › peer-review
-
Persistent dysregulation of cellular immunity following COVID-19 recovery despite minimal post-COVID-19 sequelae manifestation
Putri, D. U., Huang, C. K., Ou, T. Y., Lin, C. F., Lee, M. C., Hung, C. S. & Lee, C. H., May 2023, In: Journal of Infection. 86, 5, p. 486-488 3 p.Research output: Contribution to journal › Letter › peer-review
Open Access -
Advantages of short-course rifamycin-based regimens for latent tuberculosis infection: an updated network meta-analysis
Peng, T. R., Chen, J. H., Chang, Y. H., Shiang, J. C., Lee, M. C., Lee, C. H. & Wang, J. Y., Jun 2022, In: Journal of Global Antimicrobial Resistance. 29, p. 378-385 8 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus) -
Bisphosphonate Use Is Not Associated With Tuberculosis Risk Among Patients With Osteoporosis: A Nationwide Cohort Study
Chen, J. H., Lee, C. H., Lee, M. R., Huang, P-Y., Yen, T. H., Lee, M. C., Tsai, C. W., Wang, J. Y. & Lee, J. A., 2022, (Accepted/In press) In: Journal of Clinical Pharmacology.Research output: Contribution to journal › Article › peer-review
-
Distinct B and NKT cell responses shape the delayed response to ChAdOx1 nCoV-19 vaccine in end-stage renal disease
Putri, D. U., Lin, C. F., Hung, C. S., Huang, C. K., Ou, T. Y., Lai, C. Y., Tseng, P. C., Cheng, C. Y. & Lee, C. H., Jun 2022, In: Journal of Infection. 84, 6, p. e122-e125Research output: Contribution to journal › Letter › peer-review
Open Access
Datasets
-
Additional file 3: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119174.v1, https://springernature.figshare.com/articles/Additional_file_3_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119174/1
Dataset
-
Additional file 5: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119204.v1, https://springernature.figshare.com/articles/Additional_file_5_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119204/1
Dataset
-
Additional file 2: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119147.v1, https://springernature.figshare.com/articles/Additional_file_2_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119147/1
Dataset
-
Additional file 6: of Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Contributor), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Unknown Publisher, Apr 10 2018
DOI: 10.6084/m9.figshare.6119222.v1, https://springernature.figshare.com/articles/Additional_file_6_of_Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/6119222/1
Dataset
-
Comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in chemoprevention of hepatocellular carcinoma: a nationwide high-risk cohort study
Ho, C. (Contributor), Lee, C. (Contributor), Lee, M. (Contributor), Zhang, J. (Creator), Wang, J. (Contributor), Hu, R. (Contributor) & Lee, P. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4063952.v1, https://figshare.com/collections/Comparative_effectiveness_of_angiotensin-converting_enzyme_inhibitors_and_angiotensin_II_receptor_blockers_in_chemoprevention_of_hepatocellular_carcinoma_a_nationwide_high-risk_cohort_study/4063952/1
Dataset